TY - JOUR A2 - Bankova, Vassya AU - Chung, Vincent C. H. AU - Chen, Mao AU - Ying, Qin AU - Tam, Wilson W. S. AU - Wu, Xin Yin AU - Ma, Polly H. X. AU - Ziea, Eric T. C. AU - Wong, Vivian C. W. AU - Tang, Jin Ling PY - 2013 DA - 2013/01/10 TI - Add-On Effect of Chinese Herbal Medicine on Mortality in Myocardial Infarction: Systematic Review and Meta-Analysis of Randomized Controlled Trials SP - 675906 VL - 2013 AB - In China, Chinese herbal medicine (CHM) is widely used as an adjunct to biomedicine (BM) in treating myocardial infarction (MI). This meta-analysis of RCTs evaluated the efficacy of combined CHM-BM in the treatment of MI, compared to BM alone. Sixty-five RCTs (12,022 patients) of moderate quality were identified. 6,036 patients were given CHM plus BM, and 5,986 patients used BM only. Combined results showed clear additional effect of CHM-BM treatment in reducing all-cause mortality (relative risk reduction (RRR) = 37%, 95% CI = 28%–45%, 一世 2 = 0.0 ％ ）和心源性（RRR = 39％，95％CI = 22％-52％的死亡率， 一世 2 = 22.8 ）。好处仍然随机效应剪补调整发表偏倚（为全因死亡率= 29％，95％CI = 16％-40％的调整后RRR;调整RRR心脏死亡= 32％，95％CI = 15％-46％）。CHM也被发现在降低致死性和非致死性心源性休克，心律失常，心肌再梗死，心脏衰竭，心绞痛和心脏总事件发生的风险有效。总之，除了CHM的很可能能够改善谁已经接受BM心肌梗死患者的生存期。通过大双盲，随机临床试验确证进一步评估是必要的。SN - 1741-427X UR - https://doi.org/10.1155/2013/675906 DO - 10.1155 /六十七万五千九百○六分之二千○一十三JF - 循证补充和替代医学PB - Hindawi出版公司公司KW - ER -